Evidence map›Paper›PMID 38630060›Full record

ArticleInfectious microbes & diseases2020

Genetic Characterization of

Yujiro Hirose, Masaya Yamaguchi, Norihiko Takemoto, Tohru Miyoshi-Akiyama, Tomoko Sumitomo, Masanobu Nakata, Tadayoshi Ikebe, Tomoki Hanada, Takahiro Yamaguchi, Ryuji Kawahara and 13 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Infectious microbes & diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Emergence of clade 3Microbiology (Reading, England) · 2025
    Article
  3. Article
  4. Article
  5. Outbreak ofMicrobiology spectrum · 2024
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Yujiro HiroseDepartment of Oral and Molecular Microbiology, Osaka University Graduate School of Dentistry, Suita, Osaka, Japan.
Masaya YamaguchiDepartment of Oral and Molecular Microbiology, Osaka University Graduate School of Dentistry, Suita, Osaka, Japan.
Norihiko TakemotoDepartment of Infectious Diseases, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan.
Tohru Miyoshi-AkiyamaDepartment of Infectious Diseases, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan.
Tomoko SumitomoDepartment of Oral and Molecular Microbiology, Osaka University Graduate School of Dentistry, Suita, Osaka, Japan.
Masanobu NakataDepartment of Oral Microbiology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Tadayoshi IkebeDepartment of Bacteriology I, National Institute of Infectious Diseases, Tokyo, Japan.
Tomoki HanadaDepartment of Oral and Molecular Microbiology, Osaka University Graduate School of Dentistry, Suita, Osaka, Japan.
Takahiro YamaguchiDivision of Microbiology, Osaka Institute of Public Health, Osaka City, Osaka, Japan.
Ryuji KawaharaDivision of Microbiology, Osaka Institute of Public Health, Osaka City, Osaka, Japan.
Rumi OkunoDepartment of Microbiology, Tokyo Metropolitan Institute of Public Health, Tokyo, Japan.
Hitoshi OtsukaDepartment of Public Health Sciences, Yamaguchi Prefectural Institute of Public Health and Environment Yamaguchi City, Yamaguchi, Japan.
Yuko MatsumotoMicrobiological Testing and Research Division, Yokohama City Institute of Public Health, Yokohama, Kanagawa, Japan.
Yuji TerashimaDepartment of Microbiology, Fukushima Prefectural Institute of Public Health, Fukushima City, Fukushima, Japan.
Yu KazawaDepartment of Microbiology, Fukushima Prefectural Institute of Public Health, Fukushima City, Fukushima, Japan.
Noriko NakanishiDepartment of Infectious Diseases, Kobe Institute of Health, Kobe, Hyogo, Japan.
Kaoru UchidaDepartment of Bacteriology, Toyama Institute of Health, Imizu, Toyama, Japan.
Yumi AkiyamaInfectious Disease Research Division, Hyogo Prefectural Institute of Public Health Science, Kakogawa, Hyogo, Japan.
Kaori IwabuchiDepartment of Health Science, Iwate Prefectural Research Institute for Environmental Sciences and Public Health, Morioka, Iwate, Japan.
Chikara NakagawaDivision of Microbiology, Kyoto City Institute of Health and Environmental Sciences, Kyoto City, Kyoto, Japan.
Kazunari YamamotoNiigata City Institute of Public Health and the Environment, Niigata City, Niigata, Japan.
Victor NizetDepartment of Pediatrics, University of California at San Diego School of Medicine, La Jolla, CA, USA.
Shigetada KawabataDepartment of Oral and Molecular Microbiology, Osaka University Graduate School of Dentistry, Suita, Osaka, Japan.

Funding

Identifying the Most Effective Adjuvant(s) for Leading Group A Streptococcal Vaccine Antigens in Preclinical Mouse and Nonhuman Primate ModelsR01AI173689 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Victor Nizet, Mark Joseph Walker · 2023 to 2026
$2.8M
Broad recognition of group A Streptococcus M proteinsR21AI140436 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GHOSH, PARTHO, NIZET, VICTOR · 2018 to 2019
$426k
NIAID NIH HHS R01 AI173689NIAID NIH HHS R21 AI140436
6 · The paper itself

Abstract

Invasive infection caused by

Indexed as

clade 3emm89streptococcal toxic shock syndromeStreptococcus pyogenes

Identifiers

PMID38630060
PMCPMC7769053

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.